When was S-Biomedic founded?

S-Biomedic was founded in 2013 and raised its 1st funding round 4 years after it was founded.

Where is S-Biomedic located?

S-Biomedic is headquartered in Magdeburg, Germany.

How many employees does S-Biomedic have?

As of Apr 30, 2026, the latest employee count at S-Biomedic is 22.

Is S-Biomedic a funded company?

S-Biomedic is a funded company, having raised a total of $6.86M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Feb 09, 2017.

When was the latest funding round of S-Biomedic?

S-Biomedic's latest funding was a $***** Series A round on Sep 29, 2021, with participation from 1 investor.

Where does S-Biomedic rank among its competitors?

S-Biomedic ranks 3rd amongst 42 active competitors, of which 5 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was ZEO ScientifiX, which secured $500K in Nov, 2025.

Who are the top competitors of S-Biomedic?

S-Biomedic's top competitors include Galderma, Sinclair and Sirona Biochem. Among them, ZEO ScientifiX secured the most recent funding round in November, 2025.

S-Biomedic - 2026 Company Profile, Team, Funding & Competitors

Company Details

S-Biomedic develops probiotic cosmetic products for skin care. Its cosmetic products contain cultures of live 'beneficial' microbes for dermatology. Its first product is a topical gel for acne skin recovery.

Website: www.sbiomedic.com/
Social
Email ID: *****@sbiomedic.com

Key Metrics

Founded Year

2013

Location

Magdeburg, Germany

Stage

Acquired

Total Funding

$6.86M in 5 rounds

Latest Funding Round

Series A, Sep 29, 2021, $*****

Investors

Beiersdorf & 9 more

Ranked

3^rd among 42 active competitors

Employee Count

22 as on Apr 30, 2026

Similar Companies

Galderma & 42 more

Exit Details

Acquired by Beiersdorf (Dec 16, 2022)

View S-Biomedic's full profile

S-Biomedic is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
S-Biomedic CIN: 0668.407.105 , Norway, Active		-	-

S-Biomedic got acquired by Beiersdorf on Dec 16, 2022.

Click here to take a look at S-Biomedic's acquisition in detail

S-Biomedic has raised a total funding of $6.86M over 5 rounds. Its first funding round was on Feb 09, 2017. Its latest funding round was a Series A round on Sep 29, 2021 for $*****. 1 investor participated in its latest round. S-Biomedic has 10 institutional investors.

Here is the list of recent funding rounds of S-Biomedic:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 29, 2021	2306027	Series A	7409386	8145580	1774060	4573339
Feb 01, 2020	6972412	Grant (prize money)	7656573	2421893	8814802	Europa
Feb 18, 2019	8925723	Series A	3266734	6773404	DSM	4435650

Access funding benchmarks and valuations. Sign up today!

View details of S-Biomedic's funding rounds and investors

The founders of S-Biomedic are Marc Guell, Veronika Oudova and Bernhard Paetzold.

Here are the details of S-Biomedic's key team members:

Marc Guell: Co-Founder of S-Biomedic.
Veronika Oudova: Co-Founder of S-Biomedic.
Bernhard Paetzold: Founder of S-Biomedic.

View details of S-Biomedic's Founder profiles and Board Members

S-Biomedic's employee count trend

S-Biomedic has 22 employees as of Apr 26. Here is S-Biomedic's employee count trend over the years:

Uncover S-Biomedic's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of S-Biomedic include Galderma, Sinclair and Sirona Biochem. Here is the list of Top 10 competitors of S-Biomedic, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Galderma 1981, Zug (Switzerland), Public	Manufacturer of products to treat a range of dermatological conditions	-	ADIA, Aisling Capital & 1 others	63/100
2nd	Sinclair 1971, London (United Kingdom), Acquired	Manufacturer of injectable and energy-based device treatments for aesthetic purposes	-	Hayfin, Global Emerging Markets	52/100
3rd	S-Biomedic 2013, Magdeburg (Germany), Acquired	Probiotic cosmetic products for skin care.	$6.86M	DSM, Verve Ventures & 8 others	49/100
4th	Sirona Biochem 2006, Vancouver (Canada), Public	Developer of therapeutics for the treatment of skincare	-	Jiangsu Wanbang Biochemical Pharmaceutical	48/100
5th	ZEO ScientifiX 2011, Fort Lauderdale (United States), Seed	Biopharmaceutical company focused on researching novel biological therapeutics	$1M	-	48/100
6th	Allergan Aesthetics 2006, Irvine (United States), Unfunded	Provider of aesthetic medicine products and technologies. It develops and markets a portfolio of injectables, including fillers and neurotoxins, for facial aesthetics and body contouring. The company also offers devices for fat reduction, muscle toning, and skin resurfacing. Additionally, it provides breast implants and other related products. The focus is on providing solutions for improving the appearance and profile of various body areas.	-	-	44/100
7th	Telomir Pharmaceuticals 2021, Baltimore (United States), Public	Developer of a small molecule designed to combat aging and disease	$1M	Starwood Property Trust	41/100
8th	Jeune 2019, Pittsburgh (United States), Unfunded	Developer of gene-based treatments for photo-damaged skin	-	-	39/100
9th	Ponce Therapeutics 2019, Surfside (United States), Funding Raised	Developer of therapeutics for aging-associated skin disorders	-	Rapha Capital Management	38/100
10th	PB&B 2013, Lausanne (Switzerland), Series A	Cosmetic fillers and anti-aging medicine for healthcare aesthetics	$9M	MedTech Innovator, Octane & 2 others	37/100